Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 12:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1921–1944 of 21,991 matching trials from the live ClinicalTrials.gov search.

Filters: Recruiting Clear all

Conditions: Gastric or Gastroesophageal Junction Adenocarcinoma
Interventions: Utidelone Capsule, Fluoropyrimidine- and Platinum-containing Therapy, Oxaliplatin, PD-1 inhibitor, Capecitabine; Drug
Lead sponsor: Beijing Biostar Pharmaceuticals Co., Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 778 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Hialeah, Florida

Conditions: Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Interventions: Mosunetuzumab, Tocilizumab, Venetoclax, Rituximab; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 332 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2032
U.S. locations: 5
States / cities: Rochester, Minnesota • New York, New York • Columbus, Ohio + 2 more

Conditions: Stress, Blood Pressure, Cardiovascular Diseases (CVD)
Interventions: Stress Management and Resiliency Training Program, Usual Care; Behavioral · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older · Female only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Brain Concussion, Mild Traumatic Brain Injury, Motor Disorders, Cognitive Impairment
Interventions: tDCS in Youth with mild traumatic brain injury; Device
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 10 Years to 15 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients, Metastatic Colorectal Cancer (CRC), Peripheral Neuropathy Due to Chemotherapy
Interventions: Cannabidiol (CBD), oxaliplatin-based chemotherapy; Drug
Lead sponsor: Fox Chase Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Ischemic Stroke, Obstructive Sleep Apnea
Interventions: PAP, HLE; Device · Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Advanced Cancer, Metastatic Cancer
Interventions: Q901, KEYTRUDA® (pembrolizumab); Drug
Lead sponsor: Qurient Co., Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 7
States / cities: Phoenix, Arizona • Los Angeles, California • Jacksonville, Florida + 4 more

Conditions: Opioid-Induced Esophageal Dysfunction
Interventions: Opioid cessation, No opioid cessation; Behavioral · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Polycystic Ovary Syndrome (PCOS), Polycystic Ovary Syndrome, PCOS
Interventions: Cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells; Biological
Lead sponsor: The Foundation for Orthopaedics and Regenerative Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Naples, Florida

Conditions: Healthy Subjects (HS)
Interventions: vagus nerve stimulation; Device
Lead sponsor: Youngstown State University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Youngstown, Ohio

Conditions: Enlarged Prostate (BPH), Benign Prostatic Hyperplasia
Interventions: Magneto 150 holmium laser, Moses 2.0 holmium laser; Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: B-cell Non-Hodgkins Lymphoma (B-NHL)
Interventions: Odronextamab, REGN5837; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 9
States / cities: Duarte, California • Santa Monica, California • Louisville, Kentucky + 4 more

Conditions: Berger Disease, Bergers Disease, IgA Nephropathy, Immunoglobulin A Nephropathy, Primary IgAN, Nephritis IgA Type, Nephropathy IgA Type
Interventions: Drug: Atrasentan; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 2 Years to 18 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 4
States / cities: Neptune City, New Jersey • Cincinnati, Ohio • Oklahoma City, Oklahoma + 1 more

Conditions: B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Interventions: Not listed
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Not listed
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Infertility
Interventions: Laser Assisted Hatching; Other
Lead sponsor: Reproductive Medicine Associates of New Jersey; Other
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Marlton, New Jersey

Conditions: Parkinson Disease
Interventions: Immediate treatment, Deferred treatment; Behavioral
Lead sponsor: Teachers College, Columbia University; Other
Eligibility: 50 Years to 80 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Total Knee Arthroplasty
Interventions: Intra-articular Posteromedial Surgeon Administered (IPSA) Block of EXPAREL, Adductor Canal Block (ACB) and Local Local Infiltration Analgesia of EXPAREL, Local Infiltration Analgesia (LIA) of EXPAREL; Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: Not listed
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Gastroschisis
Interventions: Early Feeding Protocol; Procedure
Lead sponsor: University of California, Davis; Other
Eligibility: 0 Days to 1 Year
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Los Angeles, California • Sacramento, California

Conditions: Food Insecurity, Hypertension, Nutrition, Disease Management
Interventions: Food Resources & Kitchen Skills (FoRKS), Enhanced Usual Care (EUC); Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 35 Years to 75 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Brain Metastases
Interventions: Stereotactic Radiosurgery; Radiation
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2029
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Perinatal Depression, Post Partum Depression, Major Depressive Disorder
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer, Carcinoma Non Small Cell Lung
Interventions: Ubamatamab, Marlotamig, Sarilumab; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 18
States / cities: Birmingham, Alabama • Goodyear, Arizona • Irvine, California + 14 more

Conditions: Kidney Failure, Chronic, Peritoneal Dialysis Complication, Transplantation, Healthy
Interventions: biopsy sampling; Procedure
Lead sponsor: Heidelberg University; Other
Eligibility: 1 Day to 90 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2028
U.S. locations: 3
States / cities: Birmingham, Alabama • Kansas City, Missouri • Narberth, Pennsylvania

Conditions: Heart Failure
Interventions: Ertugliflozin, Metolazone, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: New Haven, Connecticut

Search by objective public record fields.

Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Adapting a Stress Management Intervention to Reduce Cardiovascular Disease Risk

Neuromodulation and Neuroimaging in Older Children With Mild Traumatic Brain Injury

Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy

The Recovery in Stroke Using PAP Study

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for PCOS

Vagus Nerve Stimulation for Reaction Time

Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

CAR T-cell Long-Term Follow-Up, Quality of Life and Adverse Reactions

Investigating Micro-Manipulation Procedures for Assisted Hatching Timing

Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease

Effectiveness of Exparel Anesthetic Administered by the Surgeon During Knee Surgery

Early Feeds in Gastroschisis

Delivering Food Resources & Kitchen Skills (FoRKS) to Adults With Food Insecurity and Hypertension

Stereotactic Radiosurgery Dose Escalation for Brain Metastases

Accelerated TMS for Perinatal Depression

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

International (Pediatric) Peritoneal Biobank

Ertugliflozin in Chronic Heart Failure